Your browser doesn't support javascript.
loading
Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma.
Tang, Kai Dun; Weeramange, Chameera Ekanayake; Vider, Jelena; Hartel, Gunter; West, Nicholas P; McMillan, Nigel A J; Batstone, Martin D; Liu, Zhen; Vasani, Sarju; Kenny, Liz; Punyadeera, Chamindie.
Afiliação
  • Tang KD; Queensland University of Technology, Centre for Biomedical Technologies, Faculty of Health, School of Biomedical Sciences, Saliva & Liquid Biopsy Translational Laboratory, Queensland 4059, Australia; Translational Research Institute, Queensland 4102, Australia; Nankai University, TEDA School of
  • Weeramange CE; Queensland University of Technology, Centre for Biomedical Technologies, Faculty of Health, School of Biomedical Sciences, Saliva & Liquid Biopsy Translational Laboratory, Queensland 4059, Australia; Translational Research Institute, Queensland 4102, Australia.
  • Vider J; Griffith University, Menzies Health Institute Queensland, School of Pharmacy and Medical Sciences, Queensland 4222, Australia; Griffith University, Menzies Health Institute Queensland, Systems Biology and Data Science, Queensland 4222, Australia; Griffith University, Institute for Glycomics, Queensl
  • Hartel G; QIMR Berghofer Medical Research Institute, Statistics Unit, Queensland 4006, Australia.
  • West NP; Griffith University, Menzies Health Institute Queensland, School of Pharmacy and Medical Sciences, Queensland 4222, Australia; Griffith University, Menzies Health Institute Queensland, Systems Biology and Data Science, Queensland 4222, Australia.
  • McMillan NAJ; Griffith University, Menzies Health Institute Queensland, School of Pharmacy and Medical Sciences, Queensland 4222, Australia.
  • Batstone MD; Royal Brisbane and Women's Hospital, Oral and Maxillofacial Surgery Department, Queensland 4029, Australia.
  • Liu Z; Royal Brisbane and Women's Hospital, Department of Otolaryngology, Queensland 4029, Australia.
  • Vasani S; Royal Brisbane and Women's Hospital, Department of Otolaryngology, Queensland 4029, Australia.
  • Kenny L; Royal Brisbane and Women's Hospital, Department of Cancer Care Services, Queensland 4029, Australia; The University of Queensland, School of Medicine, Queensland 4072, Australia; Central Integrated Regional Cancer Service, Queensland Health, Queensland 4001, Australia.
  • Punyadeera C; Queensland University of Technology, Centre for Biomedical Technologies, Faculty of Health, School of Biomedical Sciences, Saliva & Liquid Biopsy Translational Laboratory, Queensland 4059, Australia; Translational Research Institute, Queensland 4102, Australia; Griffith University, Griffith Inst
Oral Oncol ; 135: 106215, 2022 12.
Article em En | MEDLINE | ID: mdl-36274347
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oral Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oral Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article